Biomerica Statistics
NASDAQ: BMRAHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
1.91-0.23 (-10.75%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Biomerica by the numbers
Biomerica has a market capitalization of $8.8 million based on 4.60M shares outstanding. With trailing EPS of $-1.30, Biomerica is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 4.4% below its 50-day average and 9.9% below its 200-day average.
Average daily trading volume is 70.89K shares, or about $135,390 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
BMRA valuation vs. peer median
| Metric | BMRA | Peer median | Difference |
|---|---|---|---|
| Market cap | $8.78M | $6.30M | +39% |
| Avg. volume | 70.89K | 190.17K | -63% |
Peer median across 8 companies: VNRX, CDIO, TRIB, QCLS, VRAX, ICCC, IMDX, NNNN.
Valuation
- Market cap
- $8.78M
- Forward P/E
- 4.90
- EPS (TTM)
- $-1.30
- Shares outstanding
- 4.60M
Price and trading
- Previous close
- 2.14
- Open
- 2.10
- Day range
- 1.90 – 2.10
- 52-week range
- 1.45 – 3.21
- 52-week change
- -32.75%
- Beta
- —
- Volume
- 34.54K
- Average volume
- 70.89K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 13, 2026
Additional statistics
- Market Cap
- 8.78M
- Forward Pe
- 4.90
- Eps
- -1.30
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.21
- Week52 Low
- 1.45
- Avg Volume
- 70,885.00
- Shares Outstanding
- 4.60M
- Ma50
- 2.00
- Ma200
- 2.12
- Earnings Date
- Oct 13, 2026
- Pct From52w High
- -40.50%
- Pct From52w Low
- 31.72%